Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth
1. Fractyl Health appoints two new Independent Directors to its Board. 2. New appointments align with developing Revita and Rejuva products. 3. Revita data expected this month, crucial for Fractyl’s growth. 4. Healthcare expertise of new directors strengthens Fractyl's market position. 5. Fractyl aims to transform obesity and T2D treatment through innovative therapies.